We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

87 hedge funds and large institutions have $190M invested in Lifecore Biomedical in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 4

53% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 19

13% more funds holding

Funds holding: 77 → 87 (+10)

1.2% less ownership

Funds ownership: 67.39% → 66.19% (-1.2%)

6% less capital invested

Capital invested by funds: $203M → $190M (-$12.5M)

11% less call options, than puts

Call options by funds: $24K | Put options by funds: $27K

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
87
Holders Change
+10
Holders Change %
+12.99%
% of All Funds
1.17%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.08%
New
15
Increased
29
Reduced
19
Closed
4
Calls
$24K
Puts
$27K
Net Calls
-$3K
Net Calls Change
-$276K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$922K
2
LPL Financial
LPL Financial
California
+$907K
3
Millennium Management
Millennium Management
New York
+$627K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$402K
5
Boston Partners
Boston Partners
Massachusetts
+$212K

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$4.13M
2
BFM
Boothbay Fund Management
New York
-$647K
3
Marshall Wace
Marshall Wace
United Kingdom
-$406K
4
DA
DCF Advisers
Connecticut
-$354K
5
RC
Rangeley Capital
Connecticut
-$325K
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
76
GAMMA Investing
California
$3.57K +$2.01K +323 +176%
SCM
77
Sterling Capital Management
North Carolina
$3.06K -$2.06K -332 -43%
PNC Financial Services Group
78
PNC Financial Services Group
Pennsylvania
$3.03K +$1.19K +192 +80%
FFO
79
Fortitude Family Office
Arizona
$1.87K – – –
SIC
80
SJS Investment Consulting
Ohio
$1.23K +$1.08K +174 New
Nisa Investment Advisors
81
Nisa Investment Advisors
Missouri
$810 +$230 +37 +47%
Fifth Third Bancorp
82
Fifth Third Bancorp
Ohio
$472 -$392 -63 -48%
EWA
83
EverSource Wealth Advisors
Alabama
$458 +$292 +47 +261%
LSA
84
Leonteq Securities AG
Switzerland
$183 – – –
TWD
85
True Wealth Design
Ohio
$43 +$37 +6 New
HNB
86
Huntington National Bank
Ohio
$7 – – –
IA
87
IFP Advisors
Florida
$7 – – –
Invesco
88
Invesco
Georgia
– -$4.13M -555,607 Closed
BFM
89
Boothbay Fund Management
New York
– -$647K -87,142 Closed
RC
90
Rangeley Capital
Connecticut
– -$325K -43,700 Closed
DC
91
Diametric Capital
Massachusetts
– -$321K -43,146 Closed
1 2 3
4

LFCR Hedge Fund Activity: Q1 2025 in Review

87 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q1 2025, worth a combined $190M — down 6.2% from $203M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new LFCR positions and 4 closed out — a net gain of 11 holders — while 29 added to existing stakes and 19 trimmed.

The largest buyer was BlackRock, adding an estimated $922K. The largest seller was Invesco, exiting entirely with an estimated $4.13M sold.

  • 87 institutional investors held Lifecore Biomedical (LFCR) as of Q1 2025, up from 77 in Q4 2024.
  • Funds reported $190M of Lifecore Biomedical stock for Q1 2025, down 6.2% quarter-over-quarter.
  • 15 funds opened new Lifecore Biomedical positions in Q1 2025 and 4 closed out, a net change of +11 holders.
  • The largest Lifecore Biomedical buyer in Q1 2025 was BlackRock, an estimated $922K added.
  • The largest Lifecore Biomedical seller in Q1 2025 was Invesco, an estimated $4.13M sold.

Based on aggregated 13F filings for Q1 2025.